Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: Discovery and validation

Epigenetics

Volumn 10, Issue 2, 2015, Pages 135-141

  Numata, Shusuke ^a   Ishii, Kazuo ^b   Tajima, Atsushi ^a,c   Iga, Jun Ichi ^a   Kinoshita, Makoto ^a   Watanabe, Shinya ^a   Umehara, Hidehiro ^a   Fuchikami, Manabu ^d   Okada, Satoshi ^d   Boku, Shuken ^e   Hishimoto, Akitoyo ^e   Shimodera, Shinji ^f   Imoto, Issei ^a   Morinobu, Shigeru ^d,f   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KOCHI UNIVERSITY   (Japan)

Author keywords

Biomarkers; Blood; DNA methylation; Epigenetic; Major depressive disorder; Microarray; Multiplex

Indexed keywords

BIOLOGICAL MARKER; CAPRIN 1; CELL CYCLE PROTEIN; DIACYLGLYCEROL KINASE; GENOMIC DNA; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG; GENETIC MARKER; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ADULT; ARTICLE; BIOINFORMATICS; CITED2 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DSM-IV; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; GSK3B GENE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MALE; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; BLOOD; CPG ISLAND; DEPRESSIVE DISORDER, MAJOR; GENETIC MARKER; GENETICS; LEUKOCYTE; METABOLISM; MIDDLE AGED;

ADULT; CPG ISLANDS; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; FEMALE; GENETIC MARKERS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED;

EID: 84925013922     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2014.1003743     Document Type: Article

References (45)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6):593-602; PMID:15939837; http://dx.doi.org/10.1001/archpsyc.62.6.593
2. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2197-223; PMID:23245608
3. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013; 10(11):e1001547; PMID:24223526; http://dx.doi.org/10.1371/journal.pmed.1001547
4. Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009; 374(9690):609-19; PMID:19640579; http://dx.doi.org/10.1016/S0140-6736(09)60879-5
5. Petronis A, Gottesman II, Crow TJ, DeLisi LE, Klar AJ, Macciardi F, McInnis MG, McMahon FJ, Paterson AD, Skuse D, et al. Psychiatric epigenetics: a new focus for the new century. Mol Psychiatry 2000; 5:342-346; PMID:10889541; http://dx.doi.org/10.1038/sj.mp.4000750
6. Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009; 65(9):760-9; PMID:19150054; http://dx.doi.org/10.1016/j.biopsych.2008.11.028
7. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 2005; 25(47):11045-54; PMID:16306417; http://dx.doi.org/10.1523/JNEUROSCI.3652-05.2005
8. Byrne EM, Carrillo-Roa T, Henders AK, Bowdler L, McRae AF, Heath AC, Martin NG, Montgomery GW, Krause L, Wray NR. Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin. Transl Psychiatry 2013; 3:e269; PMID:23756378; http://dx.doi.org/10.1038/tp.2013.45
9. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 2011; 6(8):e23881; PMID:21912609
10. Na KS, Chang HS, Won E, Han KM, Choi S, Tae WS, Yoon HK, Kim YK, Joe SH, Jung IK, et al. Association between Glucocorticoid Receptor Methylation and Hippocampal Subfields in Major Depressive Disorder. PLoS One 2014; 9(1):e85425; PMID:24465557
11. Zill P, Baghai TC, Schule C, Born C, Frustuck C, Buttner A, Eisenmenger W, Varallo-Bedarida G, Rupprecht R, Moller HJ, et al. DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression. PLoS One 2012; 7(7):e40479; PMID:22808171
12. Asai T, Bundo M, Sugawara H, Sunaga F, Ueda J, Tanaka G Ishigooka J, Kasai K, Kato T, Iwamoto K. Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J Neuropsychopharmacol 2013; 16(10):2285-94; PMID:23931339; http://dx.doi.org/10.1017/S1461145713000710
13. D’Addario C, Dell’Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E, Galimberti D, Fenoglio C, Cortini F, Scarpini E, et al. Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 2012; 37 (7):1647-55; PMID:22353757; http://dx.doi.org/10.1038/npp.2012.10
14. Melas PA, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A, Werme M, Wegener G, Mathe AA, Svenningsson P, et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol 2012; 15(5):669-79; PMID:21682946; http://dx.doi.org/10.1017/S1461145711000940
15. Spijker S, Van Zanten JS, De Jong S, Penninx BW, van Dyck R, Zitman FG, Smit JH, Ylstra B, Smit AB, Hoogendijk WJ. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry. 2010; 68(2):179-86; PMID:20471630; http://dx.doi.org/10.1016/j.biopsych.2010.03.017
16. Savitz J, Frank MB, Victor T, Bebak M, Marino JH, Bellgowan PS, McKinney BA, Bodurka J, Kent Teague T, Drevets WC. Inflammation and neurological disease- related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav Immun. 2013; 31:161-71; PMID:23064081; http://dx.doi.org/10.1016/j.bbi.2012.10.007
17. Weber H, Kittel-Schneider S, Gessner A, Domschke K, Neuner M, Jacob CP, Buttenschon HN, Boreatti-Hummer A, Volkert J, Herterich S, et al. Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology 2011; 36(10):2076-85; PMID:21654738; http://dx.doi.org/10.1038/npp.2011.98
18. Oh DH, Park YC, Kim SH. Increased glycogen synthase kinase-3b mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database. Psychiatry Investig 2010; 7(3):202-7; PMID:20927309; http://dx.doi.org/10.4306/pi.2010.7.3.202
19. Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, et al. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci U S A 2013; 110(21):8708-13; PMID:23650397; http://dx.doi.org/10.1073/pnas.1300886110
20. Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS. In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004; 29 (8):1426-31; PMID:15039769; http://dx.doi.org/10.1038/sj.npp.1300439
21. Kinoshita M, Numata S, Tajima A, Shimodera S, Ono S, Imamura A, Iga J, Watanabe S, Kikuchi K, Kubo H, et al. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med 2013; 15 (1):95-101; PMID:22961555; http://dx.doi.org/10.1007/s12017-012-8198-6
22. Papakostas GI, Shelton RC, Kinrys G, Henry ME, Bakow BR, Lipkin SH, Pi B, Thurmond L, Bilello JA. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 2013; 18(3):332-9; PMID:22158016; http://dx.doi.org/10.1038/mp.2011.166
23. Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, Yang de Y, Fan SH, Chen L, Fang L, et al. Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 2012; 11 (3):1741-8; PMID:22239730; http://dx.doi.org/10.1021/pr2010082
24. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008; 13(2):197-207; PMID:17486107; http://dx.doi.org/10.1038/sj.mp.4002012
25. Berridge MJ. The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling. JAMA 1989; 262(13):1834-41; PMID:2674489; http://dx.doi.org/10.1001/jama.1989.03430130110043
26. Manji HK, Lenox RH. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999; 46 (10):1328-51. Review; PMID:10578449; http://dx.doi.org/10.1016/S0006-3223(99)00235-8
27. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65(4):391-426. Review; PMID:11527574; http://dx.doi.org/10.1016/S0301-0082(01)00011-9
28. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, et al. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 2009; 66 (7):721-8; PMID:19581563; http://dx.doi.org/10.1001/archgenpsychiatry.2009.70
29. Tsai SJ, Liou YJ, Hong CJ, Yu YW, Chen TJ. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Pharmacogenomics J 2008; 8(6):384-90; PMID:18195729; http://dx.doi.org/10.1038/sj.tpj.6500486
30. Zhang K, Yang C, Xu Y, Sun N, Yang H, Liu J, Xu Q, Shen Y. Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm 2010; 117(3):393-401; PMID:20033742; http://dx.doi.org/10.1007/s00702-009-0360-4
31. Saus E, Soria V, Escaramıs G, Crespo JM, Valero J, Gutierrez-Zotes A, Martorell L, Vilella E, Menchon JM, Estivill X, et al. A haplotype of glycogen synthase kinase 3b is associated with early onset of unipolar major depression. Genes Brain Behav 2010; 9(7):799-807; PMID:20618448; http://dx.doi.org/10.1111/j.1601-183X.2010.00617.x
32. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 1996; 93(16):8455-9; PMID:8710892; http://dx.doi.org/10.1073/pnas.93.16.8455
33. Jiang C, Salton SR. The role of neurotrophins in major depressive disorder. Transl Neurosci 2013; 4(1):46-58; PMID:23691270; http://dx.doi.org/10.2478/s13380-013-0103-8
34. Park SW, Lee JG, Ha EK, Choi SM, Cho HY, Seo MK, Kim YH. Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SHSY5Y cells. Eur Neuropsychopharmacol 2009; 19 (5):356-62; PMID:19196496; http://dx.doi.org/10.1016/j.euroneuro.2008.12.012
35. Park SW, Phuong VT, Lee CH, Lee JG, Seo MK, Cho HY, Fang ZH, Lee BJ, Kim YH. Effects of antipsychotic drugs on BDNF, GSK-3b, and b-catenin expression in rats subjected to immobilization stress. Neurosci Res 2011; 71(4):335-40; PMID:21893111; http://dx.doi.org/10.1016/j.neures.2011.08.010
36. Lang F, Strutz-Seebohm N, Seebohm G, Lang UE. Significance of SGK1 in the regulation of neuronal function. J Physiol 2010; 588(Pt 18):3349-54; PMID:20530112; http://dx.doi.org/10.1113/jphysiol.2010.190926
37. Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011; 36(3):415-25; PMID:20399565; http://dx.doi.org/10.1016/j.psyneuen.2010.03.007
38. Schniepp R, Kohler K, Ladewig T, Guenther E, Henke G, Palmada M, et al. Retinal colocalization and in vitro interaction of the glutamate transporter EAAT3 and the serum- and glucocorticoid-inducible kinase SGK1 [correction]. Invest Ophthalmol Vis Sci 2004; 45 (5):1442-9; PMID:15111600; http://dx.doi.org/10.1167/iovs.03-0062
39. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlen SE, Greco D, et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 2012; 7(7):e41361; PMID:22848472; http://dx.doi.org/10.1371/journal.pone.0041361
40. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 2011; 88(4):450-7; PMID:21457905; http://dx.doi.org/10.1016/j.ajhg.2011.03.003
41. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aıssi D, Wahl S, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet 2014; S0140-6736(13):62674-4
42. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et al. High density DNA methylation array with single CpG site resolution. Genomics 2011; 98, 288-295; PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.2011.07.007
43. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, Gallinger S, Hudson TJ, Weksberg R. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium Human-Methylation450 microarray. Epigenetics 2013; 8 (2):203-9; PMID:23314698; http://dx.doi.org/10.4161/epi.23470
44. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004; 64:5245-50; PMID:15289330; http://dx.doi.org/10.1158/0008-5472.CAN-04-0496
45. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100:9440-5; PMID:12883005; http://dx.doi.org/10.1073/pnas.1530509100